It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Digital Health Technologies (DHTs) such as connected sensors offer particular promise for improving data collection and patient empowerment in neurology research and care. This study analyzed the recent evolution of the use of DHTs in trials registered on ClinicalTrials.gov for four chronic neurological disorders: epilepsy, multiple sclerosis, Alzheimer’s, and Parkinson’s disease. We document growth in the collection of both more established digital measures (e.g., motor function) and more novel digital measures (e.g., speech) over recent years, highlighting contexts of use and key trends.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 Medical Faculty University Hospital Düsseldorf, Department of Neurology, Düsseldorf, Germany (GRID:grid.14778.3d) (ISNI:0000 0000 8922 7789); University of Potsdam, Hasso Plattner Institute, Potsdam, Germany (GRID:grid.11348.3f) (ISNI:0000 0001 0942 1117)
2 University of Potsdam, Hasso Plattner Institute, Potsdam, Germany (GRID:grid.11348.3f) (ISNI:0000 0001 0942 1117)
3 Brigham and Women’s Hospital, Division of General Internal Medicine and Primary Care, Boston, USA (GRID:grid.62560.37) (ISNI:0000 0004 0378 8294); Mass General Brigham, Somerville, USA (GRID:grid.32224.35) (ISNI:0000 0004 0386 9924); Harvard Medical School, Department of Biomedical Informatics, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X)
4 Medical Faculty University Hospital Düsseldorf, Department of Neurology, Düsseldorf, Germany (GRID:grid.14778.3d) (ISNI:0000 0000 8922 7789)
5 University of Potsdam, Hasso Plattner Institute, Potsdam, Germany (GRID:grid.11348.3f) (ISNI:0000 0001 0942 1117); Harvard Business School, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X); Harvard-MIT Center for Regulatory Science, Boston, USA (GRID:grid.116068.8) (ISNI:0000 0001 2341 2786)